Your trusted source for investing success

Tag: neurological disorders

Ready to invest in Cannabis? Get your guide today.

Click below to get an INN Insider's Report on marijuana investing (value of $49) for FREE. Limited time offer. No credit card required.

Give me my free guide!
PreveCeutical Receives Australian State Approval to Acquire and Use Cannabis as Part of Its Research and Development Program

PreveCeutical Receives Australian State Approval to Acquire and Use Cannabis as Part of Its Research and Development Program

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”) is pleased to announce that it has received approval (the “Approval”) from the Environmental Hazards Unit of the Queensland Government (the Australian state-level authority) to acquire, store and use high-quality cannabis oil and dried cannabis plant extracts.

3D Signatures’ TeloView Can Identify Alzheimer’s Patients

3D Signatures’ TeloView Can Identify Alzheimer’s Patients

3D Signatures Inc. (TSXV:DXD) has provided clinical study results which confirm that based on a swab from the inside of a patient’s cheek, its proprietary TeloView software platform has the ability to identify patients with Alzheimer’s disease (AD) and, furthermore, distinguish between mild, moderate and severe forms of the disease.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Cannabis Weekly Round-Up: Quebec Reveals Marijuana Bill

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/cannabis-weekly-roundup/